Search Results - Pankaj Mathur

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    How to treat left ventricular thrombi- warfarin or direct oral anti-coagulants? by Pankaj Mathur, Amisha Fnu, Jawahar L. Mehta

    Published in American Heart Journal Plus (2022-01-01)
    Get full text
    Article


  2. 2

    Erratum to “How to treat left ventricular thrombi- Warfarin or direct oral anti-coagulants?” [Am. Heart J. Plus Cardiol. Res. Pract. 13 (January 2022) 100075] by Pankaj Mathur, Amisha Fnu, Jawahar L. Mehta

    Published in American Heart Journal Plus (2022-12-01)
    Get full text
    Article


  3. 3

    Artificial Intelligence, Machine Learning, and Cardiovascular Disease by Pankaj Mathur, Shweta Srivastava, Xiaowei Xu, Jawahar L Mehta

    Published in Clinical Medicine Insights: Cardiology (2020-09-01)
    Get full text
    Article


  4. 4

    Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status by David Baker, Milan Bimali, Luis Carrillo, Archana Sachedina, Daisy Alapat, Md Shadiqul Hoque, Mathew Kottarathara, Richa Parikh, Amani Erra, Angel A. Mitma, Pankaj Mathur, Yetunde Ogunsesan, Lakshmi Yarlagadda, Sravani Gundarlapalli, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, Guido Tricot, Carolina Schinke

    Published in Haematologica (2021-08-01)
    Get full text
    Article


  5. 5

    The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma by Sharmilan Thanendrarajan, Erming Tian, Pingping Qu, Pankaj Mathur, Carolina Schinke, Frits van Rhee, Maurizio Zangari, Leo Rasche, Niels Weinhold, Daisy Alapat, William Bellamy, Cody Ashby, Sandra Mattox, Joshua Epstein, Shmuel Yaccoby, Bart Barlogie, Antje Hoering, Michael Bauer, Brian A. Walker, Faith E. Davies, Gareth J. Morgan

    Published in Haematologica (2017-09-01)
    Get full text
    Article


  6. 6

    The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype by Carolina Schinke, Antje Hoering, Hongwei Wang, Victoria Carlton, Sharmilan Thanandrarajan, Shayu Deshpande, Purvi Patel, Gabor Molnar, Sandra Susanibar, Meera Mohan, Pankaj Mathur, Muthukumar Radhakrishnan, Shadiqul Hoque, Jorge Jo Kamimoto, Monica Grazziutti, Frits van Rhee, Maurizio Zangari, Giovanni Insuasti-Beltran, Daisy Alapat, Ginell Post, Shmuel Yaccoby, Joshua Epstein, Leo Rasche, Sarah Johnson, Martin Moorhead, Tom Willis, Bart Barlogie, Brian Walker, Niels Weinhold, Faith E Davies, Gareth J. Morgan

    Published in Haematologica (2017-08-01)
    Get full text
    Article


Search Tools: